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Abstract
Background: Aberrant expression of human endogenous retrovirus (HERV) elements in the W
family has previously been associated with schizophrenia, multiple sclerosis and preeclampsia. Little
is know regarding the basal expression, transcriptional regulation and functional significance of
individual HERV-elements. Since viral infections have previously been reported to transactivate
retroviral long terminal repeat regions we examined the basal expression of HERV-W elements
and following infections by influenza A/WSN/33 and Herpes simplex 1 viruses in human cell-lines.
Methods: Relative levels of transcripts encoding HERV-W elements and cellular genes were
analyzed by qPCR methods. An analysis of amplicon melting temperatures was used to detect
variations in the frequencies of amplicons in discrete ranges of such melting temperatures. These
frequency-distributions were taken as proxy markers for the repertoires of transcribed HERV-W
elements in the cells.
Results:  We report cell-specific expression patterns of HERV-W elements during base-line
conditions. Expressed elements include those with intact regulatory long terminal repeat regions
(LTRs) as well as elements flanked by truncated LTRs. Subsets of HERV-W elements were
transactivated by viral infection in the different cell-lines. Transcriptional activation of these
elements, including that encoding syncytin, was dependent on viral replication and was not induced
by antiviral responses. Serum deprivation of cells induced similar changes in the expression of
HERV-W elements suggesting that the observed phenomena are, in part, an effect of cellular stress.
Conclusion: We found that HERV-W elements, including elements lacking regulatory LTRs, are
expressed in cell-specific patterns which can be modulated by environmental influences. This brings
into light that mechanisms behind the regulation of expression of HERV-W elements are more
complex than previously assumed and suggests biological functions of these transcripts.
Published: 06 July 2006
Retrovirology 2006, 3:44 doi:10.1186/1742-4690-3-44
Received: 31 March 2006
Accepted: 06 July 2006
This article is available from: http://www.retrovirology.com/content/3/1/44
© 2006 Nellåker et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Retrovirology 2006, 3:44 http://www.retrovirology.com/content/3/1/44
Page 2 of 11
(page number not for citation purposes)
Background
Human endogenous retroviruses (HERV) are assumed to
be remnants of ancient retroviral infections of our ances-
tors' germ-line cells. HERV sequences constitute approxi-
mately 3–8% of the human genome and can be classified
into at least 31 families [1,2]. Tissue-specific hybridiza-
tion patterns toarrays of sequences representative of dif-
ferent HERV families was recently reported, indicating a
discrete and diversified regulation of their transcriptional
activities [3,4].
The differential detection of pol transcripts related to one
of these families, HERV-W [5], was previously observed in
cerebrospinal fluids obtained from patients with multiple
sclerosis [6] and patients experiencing their first manifes-
tations of schizophrenia or schizoaffective disorder [7] as
compared to control individuals. A recent study reported
similar hybridization signals to a HERV-W pol sequence in
prefrontal cortex samples from postmortem brains from
patients with a long standing history of schizophrenia or
bipolar disorder and control individuals [8].
According to Pavlicek et.al. [9] the human genome con-
tains 654 HERV-W elements, the majority of which are
comprised of long terminal repeat regions (LTR) lacking
internal sequence. The remaining elements were classified
into 2 major categories, a total of 77 retroelements with
proviral structure containing intact LTRs and complete or
partial internal sequences (gag, pol and env genes). In addi-
tion, 149 pseudoelements with internal sequences were
found, lacking the regulatory U3 region of the 5'-LTR and
the U5 region of the 3'-LTR. Structurally these copies
resemble retroviral mRNAs and are thought to originate
from LINE-mediated reverse transcription of such
mRNAs. The remaining elements were grouped together
in a third category based on lack of diagnostic regions due
to truncations [9]. Due to the absence of regulatory pro-
moter regions, these latter groups have been suggested to
be non-transcribed [9,10]. However, except for a proviral
element in ERVWE1 locus, which contains an intact env
gene encoding syncytin [11], basal transcriptional activi-
ties of individual HERV-W elements remain poorly
defined. Furthermore, potential regulation of individual
HERV-W element expression is even less studied.
Herpes simplex viruses are known to transactivate retrovi-
ral regulatory LTR regions of both exogenous and endog-
enous human retroviruses, reviewed in [12]. With regard
to HERV-W elements, induction of protein expression by
HSV-1 was recently reported [13]. Although Influenza A
virus has in one study been reported to transactivate the
HIV-1 LTR [14], the influence RNA viruses on the tran-
scriptional activities of HERV-W elements has, however,
not been studied. Consequently we investigated the tran-
scriptional activities of different HERV-W elements in
human cell-lines during baseline conditions and how
these are modulated by viral infections.
Results
Virus infection transactivates HERV-W elements
Initially, the neuroepithelioma cell-line (SK-N-MC) was
infected with increasing titers of herpes simplex virus 1
(HSV-1) or influenza A/WSN/33 viruses. 24 or 48 hours
post infection, the levels of transcripts from the latency
gene 1 of HSV-1 and segment 8 of the influenza A/WSN/
33 virus genomes were proportional to the respective
numbers of viral plaque forming units (pfu) added to the
cultures as determined by quantitative real-time PCR (Fig-
ure 1A and Figure 1B). Linear regression analyses revealed
dose-dependent elevations of the relative levels of tran-
scripts from HERV-W related gag and env genes elements
24 hours after infection with HSV-1 (Figure 1A). Cells
infected with influenza A/WSN/33 virus responded with a
dose-dependent increase in the relative levels of HERV-W
env, but not gag, transcripts (Figure 1B). Reverse tran-
scriptase controls were consistently found to be negative
(data not shown). Variations in the levels of transcripts
encoding IFN-β appeared to correlate with those from
HERV-W env  elements in response to both HSV-1 and
influenza A/WSN/33 infections. By these experiments we
were thus able to confirm the previous studies reporting
induction of HERV-W by HSV-1 and make the novel
observation that also influenza A/WSN/33 virus infection
can transactivate HERV-W elements. In following experi-
ments, 106 pfus of the influenza A/WSN/33 virus were
used, corresponding to 0.5 multiplicity of infection
(MOI).
We next investigated if similar effects of the influenza A
virus infection could be observed in other human cell-
lines. The subsequent experiments were therefore con-
ducted on the human astrocytoma cell-line, CCF-STTG1,
the human histiocytic lymphoma cell-line U937, as well
as 293F cells derived from human kidney. At baseline, all
these cell-types contained detectable levels of transcripts
from both HERV-W gag and env genes. Such transcripts
were detected at significantly elevated levels in all three
cell-types 24 hrs after infection (Figure 2A). U937 cells
exhibited the highest relative increase in the levels of these
transcripts.
Relative increases in HERV-W element transcription after 
serum deprivation
Since influenza A viruses induce the expression of a vari-
ety of cytokine and pro-apoptotic genes in infected cells,
we next investigated the levels of HERV-W transcripts in
response to double-stranded RNA or replication-incom-
petent virus. CCF-STTG1 cultures were therefore exposed
to poly(cytidylic-inosinic) acid (poly(I:C)) to activate pro-
tein kinase R (PKR) or heat-inactivated influenza A/WSN/Retrovirology 2006, 3:44 http://www.retrovirology.com/content/3/1/44
Page 3 of 11
(page number not for citation purposes)
33 virus to simulate effects of viral binding and fusion in
the absence of viral replication. Poly(I:C)-treatment elic-
ited a 33-fold increase in the levels of transcripts encoding
IFN-β indicating adequate stimulation (data not shown).
However, no significant alterations in the relative levels of
HERV-W transcripts were observed in cells treated with
poly(I:C) or heat-inactivated virus as compared to
untreated controls (data not shown). In addition to mech-
anisms mediated by PKR, influenza A virus infections can
induce apoptosis in infected cells by complex mecha-
nisms not yet fully understood [15]. We next serum
deprived the different cell-lines to induce stresses includ-
ing cellular events leading to apoptosis [16-18]. CCF-
STTG1 cells showed a small but significant increase only
in the levels of env transcripts after serum deprivation.
Serum deprived U937 cells exhibited significantly ele-
vated levels of both HERV-W gag  and  env  transcripts
whereas the expression of these transcripts remained at
baseline levels in 293F cells (Figure 2B). Thus, induction
of HERV-W expression by influenza A/WSN/33 virus
appears to be, at least partially, an effect of events leading
to apoptosis during infection. Whether the relatively
larger responses observed in infected cells as compared
with serum deprived cells stems from additional actions
of viral proteins or cellular responses to viral load remains
undetermined.
Qualitative analysis of HERV-W env and gag expression
We observed variations in Tm's of transcripts amplified in
the assays for HERV-W gag and env in response to infec-
tion or serum deprivation and between controls of the dif-
ferent cell-lines. This was taken to be indicators of
sequence variations and cloning and sequencing of ampli-
cons from each of the different Tm categories supported
this view (sequences and Tm's, Table 2). Sequenced prod-
ucts showed the greatest homology to previously identi-
fied HERV-W sequences in all cases as determined by
BLAST http://www.ncbi.nlm.nih.gov/BLAST/ analyses.
However, while each sequence was only detected in one
Tm category, every Tm category encompassed multiple
sequences. Thus, we conducted analyses of frequency dis-
tribution of amplicons into distinguishable HERV-W gag
and env Tm categories (Figure 3A and 3B respectively) and
compared these distributions between control, virus
infected and serum deprived cells. The frequency distribu-
tion of HERV-W gag amplicons in four different tempera-
ture ranges differed significantly between control and
influenza A/WSN/33 infected CCF-STTG1 and U937, but
not 293F, cells (CCF-STTG1 χ2 = 32.09, df = 3, p < 0.0001,
U937 χ2 = 8.523, df = 3, p = 0.0363). Differences were also
observed between control and serum deprived CCF-
STTG1 and 293F cells (CCF-STTG1 χ2 = 14.86, df = 3, p =
0.0019, 293F χ2 = 14.73, df = 3, p = 0.0021). Significant
differences were observed between influenza A/WSN/33
infected and serum deprived 293F and U937 cells (293F
χ2 = 17.22, df = 3, p = 0.0006, U937 χ2 = 20.63, df = 3, p
< 0.0001). Frequency distributions of HERV-W env ampli-
cons differed significantly between control, infected and
starved CCF-STTG1 cells (controls and influenza A/WSN/
33 infected samples χ2 = 34.42, df = 2, p < 0.0001, con-
trols and serum deprived cells χ2 = 12.05, df = 2, p =
0.0024, influenza A/WSN/33 infected and serum
deprived samples χ2 = 28.44, df = 2, p < 0.0001). The Tm
Gene expression in infected SK-N-MC cells Figure 1
Gene expression in infected SK-N-MC cells. Relative levels of 
transcripts from HERV-W env, HERV-W gag and IFNB1 in 
SK-N-MC cells infected with increasing doses of herpes sim-
plex type 1 (A) or influenza A/WSN/33 (B) as compared to 
uninfected control cell-cultures. Relative levels of transcripts 
from the US6 gene of herpes simplex type 1 (A) and segment 
8 of the influenza A/WSN/33 virus strain (B) were deter-
mined in infected cultures. Relative levels of viral transcripts 
were normalized to those observed in cells infected with the 
lowest dose of each virus (n controls = 4, n virus = 5).Retrovirology 2006, 3:44 http://www.retrovirology.com/content/3/1/44
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distributions of HERV-W env amplicons did, however, not
differ between control, infected or serum deprived sam-
ples of either 293F or U937 cells.
To identify the specific HERV-W elements expressed, all
sequences obtained were mapped to the human genome
using Blat searches (Table 2). For those sequences without
assignment to a unique genomic position, the numbers of
homologous matches found are given in Table 2. For
unambiguously mapped elements, 5000 upstream bases
were subsequently downloaded and subjected to Repeat-
Masker analyses for the presence of HERV-W related 5'-
LTR regions. According to these analyses, one transcribed
element on chromosome 1q42 contains an intact HERV-
W 5'-LTR whereas three transcribed elements on chromo-
somes 3q26, 12p13 and 15q21 all have partial HERV-W
5'-LTRs lacking the U3 region. An additional three tran-
scribed elements on chromosomes 5p13, 12p12 and
Xq22, however, lack discernible HERV-W 5'-LTRs.
Transactivation of specific HERV-W elements by influenza 
A virus
To determine if only proviral elements with intact 5'-LTRs
or also elements with truncations or deletions in this
region were modulated by infection, we specifically
assayed the levels of transcripts from a HERV-W proviral
element, two pseudoelements, as well as one element
devoid of identifiable LTR. We chose to analyze the levels
of transcripts from the aforementioned env gene on chro-
mosome 7q21 which is part of a proviral element and
encodes the full-length envelope protein, syncytin. Ele-
ments on chromosomes 3q26 and 11q13 were selected as
examples of HERV-W pseudoelements. The element on
3q26 was unambiguously mapped and has a long ORF
capable of encoding a putative matrix and carboxytermi-
nal-truncated capsid proteins [19]. 11q13.5 was, in a dif-
ferent study, identified as differentially expressed in blood
cells from recent onset schizophrenia patients (Yao et al,
in preparation). Finally, the unambiguously mapped
HERV-W element on 5p13 lacks identifiable LTR. Low lev-
els of env-transcripts from the proviral HERV-W element
at 7q21 were detected CCF-STTG1 and U937, but not
293F cells at base-line. Following infection, CCF-STTG1
and U937 cells displayed significantly elevated levels of
these transcripts (Figure 4). Env-transcripts from this pro-
viral element were also readily detectable in 293F cells fol-
lowing infection, thus indicated by the (∞) symbol in
Figure 4. Transcripts from the HERV-W gag gene on 3q26
were detected in all cell types studied at baseline and the
levels of these transcripts were significantly elevated (70-
fold) in infected U937, but not in CCF-STTG1 or 293F
cells. Gag-transcripts from the HERV-W pseudoelement
on chromosome 11q13 were also present in all cell-types
at baseline but were detected at significantly elevated lev-
els in both 293F and U937 cells following infection. Gag-
transcripts from the HERV-W element on 5p13, lacking
upstream LTR could not be detected in CCF-STTG1 or
293F cells either at baseline or following infection. U937
cells, however, contained readily detectable levels of 5p13
gag transcripts at baseline and were significantly elevated
(64-fold) following infection.
EZ4U assaying for syncytin mediated cytotoxicity
The transcripts encoding syncytin, found to be transacti-
vated in all cell types studied are normally only found in
a cell population in the placenta. To resolve possible func-
tional consequences of ectopic expression of this element
CCF-STTG1 cells were transfected with an expression plas-
Expression of HERV-W elements in human cell-lines follow- ing influenza A/WSN/33 virus infection (A) or serum depriva- tion (B) Figure 2
Expression of HERV-W elements in human cell-lines follow-
ing influenza A/WSN/33 virus infection (A) or serum depriva-
tion (B). CCF-STTG1, 293F and U937 cells infected with 
influenza A/WSN/33 virus (n = 7-9) were analyzed for HERV-
W related transcripts relative to uninfected control cells (n = 
7-12). Cells deprived of serum (n = 5-7) were analyzed for 
HERV-W related transcripts relative to control cells in 
serum enriched culture media (n = 5-8). Error bars indicate 
the standard error of the difference between the means of 
infected or serum deprived cells and corresponding control 
cells. Statistical significance is indicated by * = p < 0.05, ** = p 
< 0.01, *** = p < 0.001.Retrovirology 2006, 3:44 http://www.retrovirology.com/content/3/1/44
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Influence of influenza A/WSN/33 virus infection and serum deprivation on the detectable frequency distribution of transcribed  HERV-W related sequences in CCF-STTG1, 293F and U937 cells Figure 3
Influence of influenza A/WSN/33 virus infection and serum deprivation on the detectable frequency distribution of transcribed 
HERV-W related sequences in CCF-STTG1, 293F and U937 cells. (A) Distribution of detected HERV-W gag amplicons into 
four melting temperature ranges observed in control cells (n = 38-44), influenza A/WSN/33 infected cells (n = 24-39) and 
serum deprived cells (n = 11-18). (B) Distribution of detected HERV-W env amplicons into three melting temperature ranges 
observed. Statistical significance is indicated by * = p < 0.05, ** = p < 0.01, *** = p < 0.001.Retrovirology 2006, 3:44 http://www.retrovirology.com/content/3/1/44
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mid containing the full-length env gene from 7q21 encod-
ing syncytin. These cells were subsequently assayed for
mitochondrial function through the reduction of tetrazo-
lium salts. 24 hours after transfection, 25% less tetrazo-
lium salts were reduced in syncytin-transfected cells as
compared to mock-transfected cells (Unpaired t test with
Welch's correction P < 0.0001, data not shown). However,
as compared to cells over-expressing enhanced GPF, syn-
cytin expression caused a 12% decrease in cell prolifera-
tion/viability (Unpaired t test with Welch's correction P =
0.0150).
Discussion
Through melting-temperature differences of amplicons
generated using SYBR-Green chemistry followed by clon-
ing and sequencing, we here report the constitutive
expression of several different HERV-W elements in
human cell-lines. Transcripts from genomic elements
with complete, partial as well as absent 5'-LTRs were
detected. Furthermore, we report that viral infections in
vitro elevate the transcript levels from select HERV-W ele-
ments, including elements lacking HERV-W 5'-LTR regula-
tory regions.
Transcripts from elements in the HERV-W family have
previously been detected by RT-PCR in most human
organs as well as in different cell-lines of human origin
[20]. Transcripts from HERV-W pol genes were recently
reported to be present at high levels in the placenta, whole
brain, adrenal glands and testis [21]. The relative contri-
bution of the different HERV-W elements to the total lev-
els of pol transcripts in different organs was not examined.
The differences in the levels of transcripts from HERV-W
gag, pol and env genes observed in different tissues and
cell-lines might be attributed to the documented varia-
tions in promoter activities of U3-regions of HERV-W
LTRs [22,23]. In addition, enhancer elements outside of
the LTR can influence the transcriptional activities of
HERV-W LTR promoters. This has been documented for
the ERVWE1 locus on chromosome 7q21 which is regu-
lated by promoter activity in the U3 region of the 5'-LTR
as well as an upstream regulatory region [24]. Based on
our present data there is constitutive, albeit low, expres-
sion of various HERV-W elements in human cell-lines.
Moreover, the base-line relative transcript levels from dif-
ferent elements appeared to differ between these cell-
lines. Sequencing of amplified products and mapping to
genomic regions followed by RepeatMasker analysis indi-
cated the presence of transcripts from HERV-W elements
previously assumed to be transcriptionally silent due to
truncations of the U3-region or complete lack of identifi-
able 5'-LTR [9,10]. The presence of such transcripts was
subsequently verified by element-specific assays. We sug-
gest that unidentified promoters, direct the expression of
such HERV-W elements as has been described for cellular
genes [25] in other studies. An analysis of eight different
HERV-W gag transcripts previously identified in plasma
samples from recent onset schizophrenia patients [26]
revealed transcripts from one proviral element, six pseu-
doelements and one element lacking identifiable HERV-
W 5'-LTR. Thus, elements lacking LTR regulatory regions
appear to be transcribed in vivo and not only in cell-lines.
In the present study, many of the transcribed HERV-W ele-
ments which could be mapped to single genomic sites
were located in intronic regions of host genes. This is note-
worthy as this is the case for only a minority of HERV ele-
ments in general [27]. These intronic HERV-W elements
were all oriented opposite to the direction of the host gene
transcription. Our findings illustrate the importance of
detailed characterization of disease-associated transcripts
in order to approach the mechanisms underlying their
aberrant expression.
We here report that influenza A/WSN/33 can induce an
elevation in the levels, to various degrees depending on
host cell type, of transcripts related to HERV-W gag and
env. The transactivating capacity of infectious agents on
retroviral LTRs has previously been documented, e.g.
HSV-1 has been reported to transactivate HIV-1 [12]. In
Expression of specific HERV-W elements following influenza  A/WSN/33 infection Figure 4
Expression of specific HERV-W elements following influenza 
A/WSN/33 infection. Levels of transcripts from the HERV-W 
gag on chromosomes 5p13, 11q13, 3q26 and the HERV-W 
env ORF encoding syncytin on 7q21 in CCF-STTG1, 293F 
and U937 cells infected with influenza A/WSN/33 (n = 3-7) 
relative to uninfected control cells (n = 3-9). Transcripts 
from 5p13 were not detectable in CCF-STTG1 or 293F cells 
in either control or infected cells, indicated by nd (not 
detectable). Syncytin transcripts were not detected in 293F 
control cells but were readily detectable (ct 34–35 using 500 
ng input total RNA) in influenza A/WSN/33 infected cells, 
resulting in an infinite relative expression as indicated by ∞. 
Statistical significance is indicated by * = p < 0.05, ** = p < 
0.01, *** = p < 0.001.Retrovirology 2006, 3:44 http://www.retrovirology.com/content/3/1/44
Page 7 of 11
(page number not for citation purposes)
vitro, the HIV-1 LTR has been reported to be stimulated
also by influenza A virus [14]. Members of the Herpesviri-
dae family can also activate LTRs of endogenous retrovi-
ruses including those related to HERV-W [28-30], which is
also supported by our present study. Increased expression
of HERV-W related envelope protein was also reported in
response to HSV-1 but not rabies virus infection in neu-
roblastoma cells [31]. HSV-1 was recently reported to
induce the expression of HERV-W gag protein expression
[13].
We find that the mechanisms conferring transcriptional
activation of HERV-W elements upon influenza A/WSN/
33 virus infection were not related to the antiviral
response of cells to either double-stranded RNA or to viral
capsid binding and fusion. Induction of cellular stress
responses through serum deprivation did however, to
some extent, mimic the effects of virus infection in terms
of transcription of HERV-W elements. The reported rela-
tive sensitivities to serum deprivation of the cell-lines is;
U937, CCF-STTG1 and 293F in falling order [16-18]. This
sensitivity appears to correlate with the relative increases
in HERV-W element transcript levels. Interestingly, in
serum deprived 293F cells, despite no discernible influ-
ence on the relative amount of HERV-W transcripts, alter-
ations in the relative levels of the transcribed elements
were detected. The differences observed in the expression
patterns of gag or env transcripts between influenza A/
WSN/33 infection and serum deprivation suggest that the
virus has specific effects beyond those related to cellular
stresses.
Specific analysis of transcripts from 7q21 showed that the
proviral element was transactivated by influenza A/WSN/
33 virus in all cell-lines tested. Surprisingly, in U937, virus
infection elevated the levels of transcripts from elements
lacking 5'-U3 regulatory regions. In the other cell types the
degree of transactivation was less pronounced. Transcripts
from the element lacking identifiable LTR were not even
detectable in CCF-STTG1 or 293F cells at either baseline
or following infection. Thus, when examined at the indi-
vidual level, the transcriptional regulation of HERV-W ele-
ments is considerably more complex than can be revealed
by studying only the promoter activities of HERV-W LTRs.
The proviral element on 7q21, found to be transactivated
in all cell-lines studied, contains the only HERV-W gene
known to have been "domesticated" into the human
genome [32]. The product of this conserved gene is called
syncytin in light of its fusogenic activity [11,33]. Expres-
sion of syncytin is normally largely restricted to the pla-
centa, where it is proposed to contribute to the biogenesis
of the syncytiotrophoblast layer. In the present study,
ectopic expression of syncytin in an astrocytoma cell-line
was associated with a lower activity of mitochondrial
dehydrogenases as a measure of cytotoxicity. Although the
mechanisms mediating this effect remain to be identified,
our findings support possible negative influences of
ectopically expressed syncytin in multiple sclerosis
[34,35]
That viral insults induce expression of endogenous retro-
viral sequences raises questions as to the evolutionary ori-
gins of this effect. The observed HERV expression could
constitute a cellular defense reaction, with syncytin and/
or other envelope proteins acting as potential receptor
blockers, preventing further spread of the virus in analogy
to the protection it offers to Spleen Necrosis Virus infec-
tions [36]. This scenario could also be considered a case of
a viral hijacking of envelope expression in order to utilize
the immunosuppressive properties of the transmembrane
region of syncytin (reviewed in [37]). This is further sup-
ported by the presence of syncytin at the fetomaternal
interface, a region of immunological conflict between
mother and foetus [33,38]. Thus, aberrant syncytin
expression could promote immune-system evasion and
viral spread, implied indirectly by the fact that syncytin
expression is greatly enhanced by virus replication. How-
ever, the vast majority of HERV-W elements have no iden-
tifiable long ORFs. We speculate that functional
consequences of the expression of such sequences should
be sought at the level of non-coding RNA (for a review
[39]).
The present study gives no evidence of a link between
exogenous virus infection and aberrant expression of
HERV-W elements in human disease. It does, however,
raise some points of relevance for future studies regarding
the expression of HERV-W elements;
i) Environmental stressors can modulate the transcrip-
tional activities of certain HERV-W elements which could
thereby be markers for such insults. ii) Disease specific fre-
quency distribution patterns of different transcripts need
not be reflected in levels of HERV-W transcripts and can
be missed by generic methods. iii) Different cell-types
exhibit specific quantitative and qualitative differences in
the detectable patterns of transcribed HERV-W elements.
Thus, transcripts detected in one tissue can differ from
those detected in other tissues in response to a common
insult. iv) Non-coding HERV-W elements are apparently
transcribed which should merit studies into their tran-
scriptional regulation and biological relevance.
Methods
Cell types
Human neuroepithelioma cells, SK-N-MC (HTB-10),
were grown in Dulbecco's Modified Eagle Medium: Nutri-
ent Mixture F-12 (D-MEM/F-12) supplemented with 4
mM L-glutamine, 15 mM HEPES and 12.5% FBS. HumanRetrovirology 2006, 3:44 http://www.retrovirology.com/content/3/1/44
Page 8 of 11
(page number not for citation purposes)
astrocytoma cells, CCF-STTG1 (CRL-1718), and human
histiocytic lymphoma cells, U-937 (CRL-1593.2), were
grown in RPMI 1640 adjusted to contain 1,5 g/l NaHCO3,
4,5 g/l glucose, 10 mM HEPES and 1.0 mM Na-pyruvate.
293F cells, derived from human kidney, purchased from
Invitrogen (Carlsbad, CA), were grown in D-MEM/F-12.
All other cell-lines were obtained from the American Type
Culture Collection, Manassas, VA. All cell culture media
were supplemented with 10% FBS and penicillin/strepto-
mycin (Invitrogen) unless otherwise specified.
Virus infection of cells in culture
SK-N-MC cells, plated 18 hours prior to infection in 6-
well tissue culture trays, were rinsed twice with Hank's
Balanced Salt Solution w/o Ca2+ or Mg2+ and then dupli-
cate wells were inoculated with MEM 4% FBS without
(negative control) or with known amounts (as deter-
mined by standard plaque assays) of HSV-1 (102 - 106
plaque forming units (pfu) per well) or influenza A/WSN/
33 virus (103 -107 pfu/well). The infections were allowed
to proceed for 24 (HSV-1) or 48 hours (influenza A) at
37°C/5% CO2 before RNA isolation, see below.
CCF-STTG1, 293F and U937 cells were washed with one
plating volume of MEM and inoculated with MEM con-
taining influenza A/WSN/33 (0.5 MOI) [40]. After 1 hr at
37°C in 5% CO2, cells were washed thrice in one plating
volume of MEM. Complete media was added and infec-
tions were allowed to proceed for 24 hrs in a humidified
5% CO2 incubator at 37°C before RNA isolation, see
below.
Heat-inactivated virus and poly(I:C) treatment
Influenza A/WSN/33 virus was inactivated by heating at
56°C for 90 minutes [41]. CCF-STTG1 cells were washed
once in a plating volume of MEM before inoculation as
described above with the exception that heat-inactivated
virus was also added to the culture medium. Poly(I:C)
(Sigma-Aldrich, St. Louis, MO) was dissolved in nuclease-
free water (Ambion Inc., Austin, TX) at 10 mg/ml and
added to CCF-STTG1 cells at a final concentration of 100
µg/ml [42].
Serum deprivation
CCF-STTG1, 293F and U937 cells were cultured in 35 mm
plates with normal growth medium. Cells were washed
with one plating volume of their corresponding growth
medium without FBS. Cells were subsequently allowed to
incubate in another plating volume of serum deprived
culture media for 24 hrs in a humidified 5% CO2 incuba-
tor at 37°C before RNA isolation, see below.
RNA preparation and reverse transcription
RNA was isolated using the RNeasy Mini kit in accordance
with instructions supplied by the manufacturer (Qiagen).
RNA was quantified by spectrophotometric analysis.
Oligo(dT)-primed cDNA was subsequently generated
from 150–500 ng of DNaseI-treated RNA (as previously
described [43]) using Superscript II reagents (Invitrogen)
according to instructions from the manufacturer. Control
reactions without the addition of reverse transcriptase
were included.
Table 1: Targets, primer and probe sequences and GenBank accession numbers of sequences used for assay design.
Target Polarity Sequence (5'-3') Acc. no.
β-actin Sense AACCGCGAGAAATCATGTTTG AY582799
Antisense CAGAGGCGTACAGGGATAGCA
HERV-W env Sense CCAATGCATCAGGTGGGTAAC n/a
Antisense GAGGTACCACAGACAAAAAATATTCCT
Syncytin Sense GTTAACTTTGTCTCTTCCAGAATCGA NM_014590
Antisense CATCAGATCGTGGGCTAGCA
Interferon-β Sense ACCTCCGAAACTGAAGATCTCCTA NM_002176
Antisense TGCTGGTTGAAGAATGCTTGA
11q13 gag Sense GTTTGCGGCACCAATCTGT n/a
Antisense CGATCTCTGGTATCTCAGGTCAATG
HSV-1 glycoprotein D Sense TTTGCGGAATTGTGTACTGGAT AY155225
Antisense GAGGCGTATGCGCTTTGG
5p13 gag Sense CCTGAGGGCCATGACTAAAGAG n/a
Antisense CCGCCTTAGGCCCAGAGT
Seg. 8 A/WSN/33 Sense CAGCACTCTCGGTCTGGACAT U13683
Antisense TCCTTCAGAATCCGCTCCACTA
HERV-W gag Sense TCAGGTCAACAATAGGATGACAACA n/a
Antisense CAATGAGGGTCTACACTGGGAACT
HERV-W 3q26.32 gag ORF, MGB-probe 6-FAM-CCTGTGGGAGTTGTT-MGB AF156961Retrovirology 2006, 3:44 http://www.retrovirology.com/content/3/1/44
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Real-time PCR and data analysis
1 µl cDNA templates, including the controls generated in
the absence of reverse transcriptase, were added to tripli-
cate 25 µl reaction mixtures using Platinum SYBR Green
qPCR Supermix UDG (Invitrogen) or TaqMan Universal
PCR Master Mix (Applied Biosystems, Foster City, CA)
reagents. An ABI Prism 7000 real-time thermocycler
(Applied Biosystems) was used for all assays. Oligonucle-
otides were designed using Primer Express (Applied Bio-
systems) and ordered from Invitrogen (SYBR Green
assays) or Applied Biosystems (TaqMan assay). The
sequences of the primers and probes with corresponding
design templates are provided in Table 1. The efficiencies
of the different assays ranged from 89–91% calculated as
previously described [44]. Representative products of each
assay were cloned and sequenced as previously described
[44]. Threshold cycle (Ct) values from the exponential
phase of the PCR amplification plot for each target tran-
script were normalized to those encoding β-actin. From
these values, fold-differences in the levels of transcripts
between the two groups were calculated according to the
formula 2-∆∆Ct [45]. The non-parametric Mann Whitney
test was used to compare the levels of transcripts between
cell treatments unless otherwise stated. The melting tem-
perature (Tm) for each amplicon was determined in the
ABIprism SDS software (Applied Biosystems) by record-
ing the temperatures corresponding to the maximal rate of
dissociation of double-stranded DNA [46]. Analysis was
performed through the classification of Tm's into discrete
temperature ranges that could reliably be distinguished
between assays. Amplicons representative of each of the
detected Tm's were cloned and sequenced. Five sequences
obtained in the HERV-W gag assay could be mapped to a
unique genomic position (Table 2A). Four gag sequences
could not be mapped to an exact position due to multiple
matches. Similarly, two of the four different W env
sequences detected could be mapped to exact positions in
the genome (Table 2B). TOPO-TA (Invitrogen) cloning
was performed according to the manufacturer's instruc-
tions. Plasmids were sequenced at KIseq (Karolinska Insti-
Table 2: Sequences and genomic positions of mapped HERV-W gag (A) and env (B) elements. Dashes indicate nucleotides that are 
identical with the prototypical HERV-W sequences. Open circles indicate gaps in sequence. Sequences that could not be 
unambiguously mapped to one genomic loci are indicated by the number of indistinguishable genomic loci found.
A
5' LTR 5' HERV-W gag  3' Tm(°C) Genomic location (strand)
Truncated GAGGAAooAGAACAACTCCCooACAGGCCAGCAGGC 80.2
± 0.2
3q26:180256375-180256406(+)
None --A---AG-------T----C--------------- 80.2
± 0.2
5p13:31432195-31432224(-)
Truncated ---------------T----C--o------------ 80.9
± 0.2
12p13:8809216-8809247(-)
None ------AG-------T----C------------A-- 79.7
± 0.2
12p12:18113623-18113657(+)
Complete ------AG-------T----CC-------------- 80.2
± 0.2
1q42:224124801-224124836(-)
n/a --------------------C--------------- 80.2
± 0.2
2 elements
n/a ------AG-------T----C--------------- 80.2
± 0.2
15 elements
n/a ------AG-----G-T----C--------------- 80.2
± 0.2
11 elements
n/a ---------------T----C--------------- 79.7
± 0.2
4 elements
B
5' LTR 5' HERV-W env 3' Tm(°C) Genomic location (strand)
n/a TCCTCCCACACAAATAGTCTGCCTACCCTC 77.6
± 0.2
5 elements
Truncated ---C---o---G------------------ 78.1
± 0.2
15q21:53385581-53385607(-)
None A----------G------------------ 78.7
± 0.2
Xq22:106102713-106102742(-)
n/a -----------G------------------ 77.6
± 0.2
5 elementsRetrovirology 2006, 3:44 http://www.retrovirology.com/content/3/1/44
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tutet) and sequences were aligned with ClustalW http://
www.ebi.ac.uk/clustalw/. Mapping of transcribed ele-
ments was performed using the BLAT algorithm (http://
genome.ucsc.edu/cgi-bin/hgBlat, May 2004 assembly).
4000 bases upstream of uniquely mapped genomic ele-
ments were screened by RepeatMasker for the presence of
HERV-W family LTRs http://www.repeatmasker.org/cgi-
bin/WEBRepeatMasker.
Mitochondrial viability in response to syncytin expression
CCF-STTG1 cells were transfected with the plasmid PH74
[5] containing the full length ORF encoding syncytin
using Lipofectamine 2000 reagents in accordance with the
manufacturer's instructions (Invitrogen). Transfection
with the pEBFP expression plasmid (Clontech, Mountain
View, CA) encoding a variant of green fluorescent protein
was used as a control for the effects of forced protein
expression. CCF-STTG1 cells were transfected with expres-
sion plasmids at 70% confluence in 96-well plates. After
24 hours of incubation at 37°C and 5% CO2, toxicity was
determined using the EZ4U kit [47] according to the man-
ufacturer's instructions (Biomedica Medizinprodukte
GmbH & Co KG, Wien).
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